News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
245,009 Results
Type
Article (14787)
Company Profile (28)
Press Release (230193)
Section
Business (75401)
Career Advice (724)
Deals (12684)
Drug Delivery (34)
Drug Development (27415)
Employer Resources (20)
FDA (5449)
Job Trends (5277)
News (121549)
Policy (9744)
Tag
2027 Pharm Country Standard (1)
Academia (640)
Accelerated approval (15)
Adcomms (4)
Allergies (49)
Alliances (12410)
ALS (59)
Alzheimer's disease (473)
Antibody-drug conjugate (ADC) (148)
Approvals (5690)
Artificial intelligence (103)
Autoimmune disease (77)
Automation (3)
Bankruptcy (103)
Best Places to Work (4116)
BIOSECURE Act (1)
Biosimilars (67)
Biotechnology (25)
Bladder cancer (77)
Brain cancer (27)
Breast cancer (295)
Cancer (1972)
Cardiovascular disease (175)
Career advice (569)
Career pathing (4)
CAR-T (71)
CDC (9)
Celiac Disease (1)
Cell therapy (210)
Cervical cancer (18)
Clinical research (24712)
Collaboration (405)
Company closure (1)
Compensation (312)
Complete response letters (13)
COVID-19 (714)
CRISPR (24)
C-suite (134)
Cystic fibrosis (32)
Data (2995)
Decentralized trials (1)
Depression (41)
Dermatology (32)
Diabetes (224)
Diagnostics (2101)
Digital health (19)
Diversity (2)
Diversity, equity & inclusion (6)
Drug discovery (62)
Drug pricing (62)
Duchenne muscular dystrophy (65)
Earnings (53382)
Editorial (23)
Employer branding (5)
Employer resources (16)
Events (39576)
Executive appointments (129)
FDA (6647)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (5)
Frontotemporal dementia (17)
Funding (330)
Gene editing (51)
Generative AI (4)
Gene therapy (192)
GLP-1 (398)
Government (1164)
Grass and pollen (1)
Guidances (340)
Healthcare (5585)
HIV (42)
Huntington's disease (29)
IgA nephropathy (26)
Immunology and inflammation (84)
Immuno-oncology (34)
Indications (62)
Infectious disease (838)
Inflammatory bowel disease (69)
Inflation Reduction Act (5)
Influenza (47)
Intellectual property (50)
Interviews (93)
IPO (7170)
IRA (17)
Job creations (1361)
Job search strategy (543)
JPM (15)
Kidney cancer (5)
Labor market (38)
Layoffs (141)
Leadership (5)
Legal (2191)
Liver cancer (30)
Longevity (4)
Lung cancer (295)
Lymphoma (185)
Machine learning (7)
Management (4)
Manufacturing (167)
MASH (72)
Medical device (4344)
Medtech (4378)
Mergers & acquisitions (5860)
Metabolic disorders (562)
mRNA (40)
Multiple sclerosis (50)
NASH (6)
Neurodegenerative disease (124)
Neuropsychiatric disorders (31)
Neuroscience (909)
NextGen: Class of 2026 (1557)
Non-profit (1173)
Now hiring (15)
Obesity (257)
Opinion (58)
Ovarian cancer (85)
Pain (61)
Pancreatic cancer (106)
Parkinson's disease (84)
Partnered (4)
Patents (93)
Patient recruitment (127)
Peanut (14)
People (11697)
Pharmaceutical (6)
Pharmacy benefit managers (7)
Phase 1 (6665)
Phase 2 (10250)
Phase 3 (9391)
Pipeline (3737)
Policy (63)
Postmarket research (1173)
Preclinical (2646)
Press Release (25)
Prostate cancer (83)
Psychedelics (12)
Radiopharmaceuticals (94)
Rare diseases (251)
Real estate (1656)
Recruiting (7)
Regulatory (7791)
Reports (25)
Research institute (555)
Resumes & cover letters (113)
Rett syndrome (16)
RNA editing (8)
RSV (43)
Schizophrenia (71)
Series A (53)
Series B (51)
Sickle cell disease (35)
Special edition (10)
Spinal muscular atrophy (51)
Sponsored (10)
Startups (835)
Stomach cancer (3)
Supply chain (27)
Tariffs (21)
The Weekly (18)
Vaccines (290)
Venture capital (23)
Weight loss (189)
Women's health (24)
Worklife (4)
Date
Last 7 days (293)
Last 30 days (888)
Last 365 days (10086)
2026 (3388)
2025 (10442)
2024 (11768)
2023 (13130)
2022 (17173)
2021 (17519)
2020 (16449)
2019 (13136)
2018 (9726)
2017 (8680)
2016 (7229)
2015 (8954)
2014 (6897)
2013 (5790)
2012 (38164)
2011 (22663)
2010 (5610)
Location
Africa (274)
Alabama (18)
Arizona (78)
Arkansas (5)
Asia (15209)
Australia (2135)
California (4253)
Canada (1227)
China (428)
Colorado (170)
Connecticut (200)
Delaware (153)
Europe (35240)
Florida (544)
Georgia (127)
Hawaii (1)
Idaho (9)
Illinois (362)
India (16)
Indiana (241)
Iowa (4)
Japan (206)
Kansas (74)
Kentucky (19)
Louisiana (19)
Maine (34)
Maryland (427)
Massachusetts (2910)
Michigan (98)
Minnesota (212)
Mississippi (2)
Missouri (49)
Montana (7)
Nebraska (7)
Nevada (41)
New Hampshire (28)
New Jersey (1502)
New Mexico (3)
New York (1089)
North Carolina (524)
North Dakota (3)
Northern California (2281)
Ohio (84)
Oklahoma (1)
Oregon (4)
Pennsylvania (839)
Puerto Rico (5)
Rhode Island (7)
South America (404)
South Carolina (21)
South Dakota (1)
Southern California (1657)
Tennessee (50)
Texas (646)
United States (14925)
Utah (115)
Virginia (78)
Washington D.C. (15)
Washington State (325)
Wisconsin (28)
245,009 Results for "13".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Atopia Therapeutics Reports Preclinical Proof-of-Concept of Lead Compound ATP-R13 in Atopic Dermatitis and Strengthens Patent Protection
- Preclinical in vivo efficacy data in atopic dermatitis extend previous PoC in allergic asthma - Positive opinion from the European Patent Office strengthens patent protection of ATP-R13 - Progress significantly enhances the strategic attractiveness of ATP-R13 as a broadly applicable, disease-modifying therapy across multiple allergic indications
January 20, 2026
·
1 min read
Press Releases
Mdxhealth to Release First Quarter 2026 Financial Results on May 13
April 30, 2026
·
1 min read
Press Releases
Seer to Report First Quarter 2026 Financial Results on May 13, 2026
April 29, 2026
·
1 min read
Press Releases
ClearPoint Neuro to Announce First Quarter 2026 Results May 13, 2026
April 29, 2026
·
4 min read
Press Releases
LogicMark, Inc. to Announce First Quarter 2026 Financial Results on May 13, 2026
April 29, 2026
·
3 min read
Press Releases
Novo Nordisk A/S - share repurchase programme - April 13, 2026
April 13, 2026
·
2 min read
Press Releases
Ipsen S.A. - Information relating to the holding of the Combined Shareholders’ Meeting of 13 May 2026
April 23, 2026
·
6 min read
Press Releases
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program - April 13, 2026
April 13, 2026
·
2 min read
Press Releases
Bionano to Report First Quarter 2026 Financial Results and Host a Conference Call Webcast on May 13, 2026
April 29, 2026
·
1 min read
Press Releases
Spyre Therapeutics Announces Proposed Public Offering of its Common Stock - April 13, 2026
April 14, 2026
·
6 min read
1 of 24,501
Next
